The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ENGOT-OV24-NSGO/AVANOVA: Niraparib versus bevacizumab-niraparib combination versus bevacizumab and niraparib as sequential therapy in women with platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer.
 
Mansoor Raza Mirza
Research Funding - Tesaro (Inst)
 
Christiane Ehlers Mortensen
No Relationships to Disclose
 
Elisabeth Avall-Lundqvist
No Relationships to Disclose
 
Line Bjorge
No Relationships to Disclose
 
Jonathan S. Berek
Consulting or Advisory Role - Atara Biotherapeutics; Prima BioMed
Research Funding - AstraZeneca (Inst); Endocyte (Inst); Genentech (Inst); Merck (Inst); Prima BioMed (Inst); Quest Diagnostics (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Prima BioMed
 
Jorn Herrstedt
No Relationships to Disclose
 
Anne Juul Holm
No Relationships to Disclose
 
Tinne Kirkegaard
No Relationships to Disclose
 
Johanna Maenpaa
No Relationships to Disclose